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Abstract 
 
Tyrosyl DNA phosphodiesterase-1 (TDP1) is the gene product mutated in spinocerebellar ataxia with 
axonal neuropathy1 (SCAN1). SCAN1 is a hereditary ataxia that lacks extra-neurological phenotype, 
pointing to a critical role for TDP1 in the nervous system. Recently, we showed that TDP1 is associated 
with the DNA single-strand break (SSBR) repair machinery through an interaction with DNA ligase 3α 
(Lig3α) and that SCAN1 cells are defective in the repair of chromosomal DNA single-strand breaks 
(SSBs) arising from abortive Topoisomerase 1 (Top1)-DNA intermediates. Here we demonstrate that 
TDP1 is also required for the repair of SSBs induced by ionizing radiation (IR), though not measurably for 
IR-induced DNA double-strand breaks (DSBs). In addition, we provide evidence that abortive Top1 
cleavage complexes are processed by the proteasome prior to the action of TDP1 in vivo, and we exploit 
this observation to show that the SSBR defect in SCAN1 following IR reflects, in part at least, the 
presence of IR-induced protein-DNA cross-links. Finally we show that TDP1 activity at abortive Top1-
SSBs is stimulated by XRCC1/Lig3α in vitro. These data expand the type of SSBs processed by TDP1 to 
include those induced by ionizing radiation, and raise the possibility that TDP1 inhibitors may improve 
radiotherapy.  
 
1. Introduction 
 
Tens of thousands of DNA single-strand breaks (SSBs) arise in each cell every day [1]. Most if not all the 
termini at these breaks lack conventional 3’-hydroxyl and 5’-phosphate and their processing is essential 
for completion of subsequent repair steps. TDP1 is a DNA end processing enzyme, the primary function 
of which is to hydrolyse the covalent bond between Top1 and the 3’-terminus of DNA in abortive Top1 
cleavage complexes [2,3]. During its normal catalytic activity, Top1 generates a “reversible” intermediate 
known as the cleavage complex, in which Top1 is covalently attached via a tyrosyl residue (human 
Tyr723) to the 3’-terminus of a single stranded nick [4,5]. These reversible complexes can, however, be 
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converted into “abortive” intermediates comprised of Top1-associated DNA single- or double-strand 
breaks by collision with the transcription machinery or with DNA replication forks [6-14]. Steady-state 
levels of cleavage complexes are increased by the Top1 inhibitor camptothecin (CPT), or by the close 
proximity of these intermediates to other types of DNA lesions or unusual DNA secondary structures [15-
21]. Biochemical and structural data suggest that intact stalled Top1 may not be good substrate for TDP1, 
implying that a conformational change or partial degradation is needed prior to TDP1 activity [22-24]. 
TDP1 may also process other types of termini, including 3’-damaged sugar moieties, though these 
activities have so far only been demonstrated in-vitro [25,26]. Mutation in the active site of TDP1 is 
associated with the human neurodegerative disease Spinocerebellar Ataxia with Axonal Neuropathy-1 
(SCAN1) [27]. SCAN1 is typified by cerebellar ataxia and progressive degeneration of the cerebellum, 
with symptoms restricted to non-dividing neuronal cells. Lymphoblastoid cells (LCLs) from SCAN1 
individuals exhibit a defect in the repair of oxidative and CPT-induced SSBs, and TDP1 is intimately 
associated with the SSBR machinery via direct interaction with DNA Lig3α [28-31]. 
Ionizing radiation (IR) is widely exploited as a modality for cancer treatment, with cellular radio-
resistance being a major unresolved problem. In order to improve radiotherapy, a better understanding of 
how cells respond to radiation damage is needed. IR induces DNA base damage, SSBs, and DSBs, with 
the latter being the primary cytotoxic lesion [32-35]. Unrepaired SSBs can be converted into DSBs during 
DNA replication, raising the possibility that SSBR inhibitors can sensitize certain types of tumors to 
radiotherapy [36,37]. Whereas the mechanisms by which IR-induced DSBs have been extensively studied 
in vivo, less is known about the repair of IR-induced SSBs. Here, we have assessed the requirement for 
TDP1 at sites of IR-induced DNA strand breaks using alkaline and neutral comet assays. We report that 
SCAN1 LCLs, harbouring mutated TDP1, exhibit a measurable delay in the rate of removal of SSBs 
induced by IR. In contrast, we did not detect a measurable delay in the repair of IR-induced DSBs, using 
the neutral comet assay. The SSBR defect in SCAN1 cells was attributed, at least in part, to the presence 
of IR-induced abortive Top1-DNA intermediates. Finally, we report that XRCC1 and DNA Lig3α weakly 
stimulate TDP1 activity at 3’-phosphotyrosine SSBs, in vitro. 
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2. Materials and Methods 
 
2.1 Cell Lines  
 
 Lymphoblastoid cell lines (LCLs) derived from SCAN1 patients and normal individuals have been 
described previously [27] and were maintained in suspension culture at a density of 2-5X105 viable 
cells/ml in RPMI 1640 supplemented with 15% foetal calf serum (FCS), 2mM L-glutamine, 100U/ml 
penicillin, and 100μg/ml streptomycin.  
 
2.2 Alkaline comet assays  
 
Cells (~3X105 cells/sample) were exposed to γ-irradiation (caesium 137, CammaeII 1000) or treated with 
CPT as indicated in the appropriate figure legend. Cells were then suspended in pre-chilled PBS and 
mixed with equal volume of 1.2% low-gelling-temperature agarose (Sigma, type VII) maintained at 42°C. 
The cell suspension was immediately layered onto pre-chilled frosted glass slides (Chance Propper) pre-
coated with 0.6% agarose and maintained in the dark at 4°C until set, and for all further steps. Slides were 
immersed in pre-chilled lysis buffer (2.5M NaCl, 10mM Tris-HCl, 100mM EDTA pH8.0, 1% Triton X-
100, 1% DMSO, pH10) for 1 hr, washed with pre-chilled distilled water (2x10min), and placed for 45 min 
in pre-chilled alkaline electrophoresis buffer (50mM NaOH, 1mM EDTA, 1% DMSO). Electrophoresis 
was then conducted at 25V (0.6V/cm) for 25 min, followed by neutralisation in 400 mM Tris-HCl pH7.0 
for 1 hr. Finally, DNA was stained with Sybr Green I (1:10,000 dilution in PBS) for 30 min. DNA strand 
breakage was expressed as “comet tail moment”, which is the product of the tail length and the fraction of 
DNA that has exited the nucleus during electrophoresis [38]. The comet tail moment was measured for at 
least 100 cells per sample using Comet Assay III software (Perceptive Instruments, UK). Where indicated, 
cells were either mock-incubated or incubated with 50 μM of the proteosome inhibitor Z-Leu-Leu-Leu-
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al (MG132; Sigma) for 2 hr prior to exposure to γ-irradiation or CPT, and during subsequent repair 
incubations.  
 
2.3 Neutral comet assays  
 
Neutral comet assays were conducted as described [39,40], with some modification. Briefly, following 
exposure to γ-irradiation, cells were embedded in agarose and layered onto frosted slides as described for 
the alkaline comet assay. Slides were then immersed in pre-chilled lysis buffer (2.5M NaCl, 10mM Tris-
HCl, 100mM EDTA pH8.0, 0.5% Triton X-100, 1% N-lauroylsarcosine, 3% DMSO, pH9.5) for 1.5 hr 
and then washed with pre-chilled distilled water (2x10min), followed by pre-chilled electrophoresis buffer 
(300mM sodium acetate, 100mM Tris-HCl, 1% DMSO, pH8.3) (2x10min). Slides were equilibrated in 
fresh electrophoresis buffer for a further 1 hr and electrophoresis was then conducted in fresh 
electrophoresis buffer at 25V (0.6V/cm) for 60 min. DNA was stained, visualised, and strand breakage 
quantified as described for the alkaline comet assay.  
 
2.4 Recombinant proteins  
 
The human ORF encoding TDP1 (Image Clone 3900062, accession no. NM 018319) was obtained from 
MRC GeneService, UK and amplified using the primers 5’-      
AGGAATTCAGGAGTATAATGCATCACCATCATCACCATCCGGATCCGATGTCTCAGGAAGGC
GATTATGGG-3’ (forward) and 5’- 
ACGAATTCGCTCAGCGTCGACTCAGGAGGGCACCCACATGTTCCC (reverse). Following 
confirmation by sequencing, the TDP1 ORF was sub-cloned into the BamH1/EcoR1 sites of pET16B [28] 
and expression of recombinant histidine-tagged TDP1 (His-TDP) induced in BL21 (DE3) E. coli with 
1mM IPTG at 30°C for 90 min. Cell pellets (from a 0.5 litre culture) were frozen until required and then 
re-suspended in 20ml sonication buffer [50mM Hepes pH8, 500mM NaCl, 10% v/v glycerol, 1mM 1,4 
dithiothreitol (DTT), 1mM phenylmethylsulphonyl fluoride (PMSF), and 1mM imidazole] and sonicated 
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for 4x30 sec on ice at 16% power (Soniprep 150, Sanyo). Soluble cell proteins (~100mg total protein) 
were mixed with 1ml bed volume of NTA-Agarose beads (Qiagen) pre-washed in Wash Buffer (25mM 
Hepes pH8, 0.1M NaCl, 10% glycerol, 1mM DTT, 1mM imidazole) on ice with gentle stirring for 20 min. 
The suspension was then added to a Polyprep disposable chromatography column (BioRad) at 4°C and 
washed with Wash Buffer (1x5 ml) followed by Wash Buffer containing 50mM imidazole (2x5ml). 
Bound proteins were then eluted with 5ml Elution Buffer (25mM Hepes pH8, 0.1M NaCl, 10% glycerol, 
1mM DTT, and 250mM imidazole) and collected in 0.5ml aliquots. Peak fractions were pooled, dialyzed 
(20mM Hepes pH8, 0.1M NaCl, 1mM DTT, 10% glycerol), and TDP1 further purified by anion exchange 
chromatochraphy (1.6ml Poros 20 HS column) using a BioCad Chromatography System. Recombinant 
human histidine-tagged DNA ligase IIIα (Lig3α) and XRCC1 proteins were expressed and purified from 
pET16BHL3α [41] and pET16BXH [42] respectively essentially as above. Note that in case of Lig3α, 
lysis and elution were conducted at the same salt concentration (500mM NaCl) throughout to retain 
solubility. XRCC1 and Lig3α were further purified by gel filteration using a Superdex 200 HR 10/30 
column (Pharmacia) at a flow-rate of 0.5ml/min. Aliquots of the purified proteins were snap frozen in 
liquid nitrogen and stored at -80°C until needed. 
 
2.5 Cell-free SSBR assays.  
 
An 18-mer oligonucleotide (18-Y; 5’-TCCGTTGAAGCCTGCTTT-P-Tyr-3’) containing a 3’ 
phosphotyrosyl terminus [2] was a generous gift from H. Nash (National Institute of Mental Health, 
Bethesda, USA). The 25-mer (5’-GACATACTAACTTGAGCGAAACGGT-3’) and 43-mer (3’-
TAGGCAACTTCGGACGAAACTGTATGATTGAACTCGCTTTGCC-5’) employed to generate a 
duplex substrate containing a nick with a 3’-phosphotyrosine terminus (see Figure 5A) were synthesized 
by MWG. The 18Y-mer was phosphorylated by T4 PNK in 25μl reactions containing 5μCi [γ-32P] ATP at 
7000Ci/mmol (ICN), and after the removal of unincorporated nucleotides annealed with equimolar 
amounts of the 25-mer and 43-mer. For repair assays, recombinant proteins were dialyzed in 25mM Hepes 
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pH8, 130mM KCl, 1 mM DTT and where indicated pre-incubated for 20 min on ice to allow formation of 
protein complexes. Recombinant proteins were mixed with 25nM duplex substrate (10μl reaction volume) 
and incubated at 37°C for 1 hr in 25mM Hepes pH8, 130mM KCl, 1mM DTT, 10mM MgCl2, and 1mM 
ATP. Reactions were stopped by addition of 1X loading buffer (44% deionized formamide, 2.25mM Tris-
borate, 0.05mM EDTA, 0.01% xylene cyanol, 1% bromophenol blue), heated at 90°C for 10 min, and 
repair products fractionated by denaturing electrophoresis at 250V. Repair products were quantified using 
Molecular Dynamics ImageQuant software (Version 4.2a).  
 
2.6 Detection of Top1-DNA complexes by immunoblotting  
 
Top1 protein-DNA complexes were detected as previously described [43,44]. Briefly, cells (2X106) were 
mock treated or incubated in 14 μM camptothecin for 1 hr at 37°C followed by lysis in 1% Sarcosyl, 8 M 
Guanidine HCl, 30 mM Tris pH 7.5 and 10 mM EDTA. Cell lysates were then incubated at 70°C for 15 
minutes to remove all non-covalently bound proteins from DNA. Cell lysates were then loaded on a 
cesium chloride (CsCl) step gradient (5 ml total volume) and centrifuged at 75,600 g at 25°C for 24 hrs to 
separate free proteins from DNA. Ten consecutive 0.5 ml fractions were collected and slot blotted onto 
Hybond-C membrane (Amersham). To ensure equal DNA loading, the DNA concentration in each extract 
was determined fluorimetrically using PicoGreen (Molecular Probes/Invitrogen). Covalent Top1-DNA 
complexes were then detected by immunoblotting with anti-Top1 polyclonal antibodies (Abcam, ab3825) 
and visualised by chemiluminescence. For quantitation, fractions containing Top1-DNA complexes (4-7) 
were pooled and serial dilutions analysed as described above. Band intensities were quantified using 
ImageQuant software (GE Healthcare).  
 
3. Results 
 
To examine whether TDP1 is required for the rapid repair of IR-induced SSBs SCAN1 lymphoblastoid 
cells (LCLs) were exposed to γ-rays (20Gy) and levels of alkali labile sites and DNA strand breaks 
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quantified using the alkaline comet assay. Although the alkaline comet assay measures both SSBs and 
DSBs, >95% of breaks induced by IR are SSBs [35]. Consequently, following IR, this assay primarily 
measures rates of SSBR. Whilst IR induced similar initial levels of DNA strand breakage in normal and 
SCAN1 cells, the kinetics of removal of these breaks was delayed in the latter (Fig 1A &1B). During a 30 
min repair period the level of IR-induced DNA strand breaks in Tdp1+/+ and Tdp1+/- LCLs declined by 
~70%, whereas in SCAN1 cells this level declined by only ~40%. After a 60 min repair period SCAN1 
cells retained ~40% of their breaks, whereas only 15% remained in normal cells (Fig 1B). These results 
were consistently observed in three independent SCAN1 cell lines. The SSBR defect in SCAN1 cells was 
evident not only from the mean tail moments from multiple, averaged, experiments, but also from scatter 
plots of the raw data from individual experiments (Fig 1C). We conclude from these experiments that the 
global rate of repair of IR-induced SSBs is decreased in SCAN1 cells.  
 We next examined whether there is a defect in the repair of IR-induced DSBs in SCAN1 cells, as 
measured by neutral comet assays. Normal and SCAN1 cells exhibited similar levels of DSBs 
immediately after irradiation and similar rates of their removal during subsequent repair-incubations (Fig 
2A & 2B). In contrast, LCLs obtained from individuals with Lig4 syndrome exhibited delayed kinetics of 
DSB removal, consistent with their established defect in DNA double-strand break repair [45,46]. It is 
worth noting that we observed similar results in primary Tdp1-/- mouse neural cells, in which we 
employed γH2AX immunostaining to quantify rates of DSBR (unpublished observations).  
 The defect in SSBR observed in SCAN1 cells following IR is much less than that observed 
following CPT [28]. This most likely reflects that all of the SSBs induced by CPT are substrates for TDP1 
whereas only a subset of IR induced lesions may be so.  What might be the nature of the IR-induced SSBs 
that are substrates for TDP1?  One possibility is that these are SSBs with 3’-phosphoglycolate (3’-PG)  
termini, since TDP1 is required to process this type of terminus at single-stranded DNA or at DSBs with 
3’-overhangs [25,47]. However, at SSBs, APE1 appears to be the major activity responsible for removing 
3’-PG, in vitro at least [48,49]. Alternatively, it is possible that the IR-induced SSBs that are processed by 
TDP1 are abortive Top1-cleavage complexes, analogous to those induced by CPT. This would be 
consistent with the observation that the types of sugar damage and base damage that are induced by IR can 
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stabilise and/or induce Top1 cleavage complexes in a manner similar to CPT [18-21]. To address these 
possibilities we took advantage of the striking observation that pre-incubation with the proteasome 
inhibitor MG-132 greatly reduces or ablates the accumulation of SSBs in SCAN1 cells, as measured by 
the alkaline comet assay, following CPT (Fig 3A). Whereas SCAN1 cells accumulated ~7-fold more SSBs 
than did normal cells during incubations with CPT in the absence of proteasome inhibitor, pre-incubation 
with MG-132 reduced the accumulation of CPT-induced SSBs in SCAN1 cells almost to the level 
observed in normal LCLs (Fig 3A & 3B). This did not reflect an impact of MG-132 on cleavage complex 
formation because the level of Top1-DNA complexes induced by CPT was largely unaffected (Fig. 3C). 
Consequently, we conclude that the proteasome is required to convert CPT-induced abortive top1 
cleavage complexes into SSBs that can be detected by the alkaline comet assay. These data are entirely 
consistent with previous observations that the proteasome may be required to process the ‘intact’ Top1 
polypeptide present in abortive cleavage complexes into a truncated-from that can be processed by TDP1 
[50-54][22-24].  
  In light of the above observations, we reasoned that if some or all of the γ ray-induced SSBs that 
were substrates for TDP1 arose from abortive Top1 cleavage complexes then their persistence in SCAN1 
cells would be reduced or ablated by pre-incubation with the MG-132. Alternatively, if the γ ray-induced 
SSBs reflected breaks induced directly by IR, then MG-132 should not impact on their persistence. We 
thus exposed normal and SCAN1 cells to γ rays (20 Gy) with or without prior incubation with MG-132 
and quantified the level of DNA strand breaks following 30 min and 60 min repair periods, in the presence 
or absence of MG-132 (Fig 4A). Whereas pre-incubation with MG-132 did not impact on the level of IR-
induced strand breaks in normal cells, it decreased the level of breaks present after a 30-60 min repair 
period in SCAN1 cells by approximately half (Fig 4A & 4B). These data provide compelling evidence that 
the SSBR defect observed in SCAN1 LCLs following IR reflects, in part at least, SSBs arising indirectly 
through formation of abortive Top1 cleavage complexes.  
The observations reported here and previously [28,30,31] demonstrate that Top1-associated SSBs 
are TDP1 substrates in cells. However, in vitro studies suggest that SSBs are poor substrates for TDP1 
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compared to single-stranded oligomers or DSBs. We thus examined whether the established association of 
TDP1 with the XRCC1/DNA Lig3α complex [28,30] might affect its activity at Top1-associated SSBs. 
The activity of TDP1 was therefore compared in the presence and absence of recombinant human DNA 
XRCC1/Lig3α using a synthetic 18-mer oligonucleotide containing a SSB with a 3’-phosphotyrosine-
linked terminus (“18-Y”) to mimic the type of terminus processed by TDP1 within a Top1-associated SSB 
[2] (Fig 5A, top). TDP1 activity was indicated in these experiments by conversion of the 18-Y substrate to 
a product that contains a 3’-phosphate (18-P), which consequently has increased electrophoretic mobility  
(Fig 5A, bottom). Based on this titration experiment, a limiting concentration of  TDP1 (1nM) was chosen 
for further analysis, and was incubated with serial dilutions (0.5, 1, or 2nM) of the indicated recombinant 
proteins or BSA, and with 18-Y substrate for 60 min at 37°C (Fig 5B). Incubation with TDP1 and BSA 
resulted in formation of significant amounts 18-mer product (Fig 5B, lanes 1-4). However, the additional 
presence of DNA Lig3α weakly stimulated the reaction (Fig 5B; lanes 5-7) and the additional presence of 
XRCC1 stimulated the reaction further (Fig 5B; compare lanes 2-4 with lanes 11-13). We did not observe 
stimulation when XRCC1 was added alone (Fig 5B; lanes 8-10), nor did we detect repair if TDP1 was 
omitted from the reaction (data not shown). Similar results were observed if TDP1, BSA, Lig3α, and/or 
XRCC1 were mixed in equimolar ratios and then titrated into reactions containing the 18-Y substrate 
(Fig.5C&D). We conclude from these experiments that XRCC1/DNA Lig3α complex stimulates TDP 
activity on tyrosine-associated SSBs. 
 
4. Discussion 
 
The results presented suggest that TDP1 is required for normal global rates of SSBR following IR. In 
contrast, we did not detect a defect in the rate of repair of IR-induced DSBs, though we cannot rule out a 
defect in the repair of a subset of DSBs too small to be detected by the neutral comet assay or by γ-H2AX 
assays (data presented here and unpublished observations). The favoured substrate for TDP1 is a 3’-
terminus covalently linked through a phosphodiester bond to the active site tyrosine of Top1 peptide. To 
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better understand the nature of the defect in repair of IR-induced SSBs in SCAN1 cells we attempted to 
distinguish between Top1-associated SSBs and other types of SSBs, in vivo. To achieve this we exploited 
our observation that the proteosome inhibitor MG-132 greatly reduced detection of CPT-induced Top1-
associated SSBs by the alkaline comet assay. We interpret this observation to indicate that alkaline comet 
assays do not detect ‘intact’ Top1 cleavage complexes, but only those that have been converted into ‘true’ 
DNA strand breaks by Top1 degradation or denaturation. This is consistent with the hypothesis that TDP1 
activity at SSBs occurs after Top1 in abortive cleavage complexes has been denatured or proteolytically 
degraded [22,53]. This is most likely necessary during the repair of abortive Top1-cleavage complexes 
because the DNA-tyrosyl linkage is buried deep within intact Top1 and thus inaccessible to TDP1 [23,24]. 
Strikingly, we found that MG-132 reduced the level of IR-induced strand breaks remaining in SCAN1 
cells after 30 min and 60 min repair periods by approximately half, as measured by alkaline comet assays. 
This suggests that at least half of the IR-induced breaks that persisted in SCAN1 cells in these experiments 
were peptide-linked, resulting most likely from Top1-cleavage complexes that were stabilised or trapped 
by other types of IR-induced lesions [17-21,55,56]. This conclusion is consistent with the observations 
that Top1-DNA cross-links are induced in HeLa cells by oxidative DNA damage and that Top1-deficient 
murine leukaemia cells and budding yeast are more resistant to oxidative damage than their wild-type 
counterparts [57].  
 The nature of the IR-induced SSBs that persisted in SCAN1 cells in the presence of 
proteosome inhibitor is unclear. It is possible that these too are Top1-associated breaks, because MG-132 
did not completely prevent the accumulation of CPT-induced breaks in SCAN1 cells, despite this Top1 
inhibitor inducing DNA breaks exclusively via stabilisation of Top1-cleavage complexes [58-60]. 
Alternatively, the MG-132 ‘resistant’ breaks that persisted in SCAN1 cells following IR may reflect 
breaks induced directly by this agent, since TDP1 can process a variety of other types of termini in vitro, 
including 3’-phosphohistidine, 3’-phosphoglycolate, 3’-abasic sites, and 3’-biotin, and even some types of 
5’-termini [25,26,47,61]. 3’-phosphoglycolate termini are of particular relevance, since these are present at 
~30% of γ-ray induced breaks [62]. Although purified TDP1 is ~100-fold less active on 3’-
phosphoglycolate compared to 3’-phosphtyrosyl [25], the repair of protruding 3’-PG at the termini of 
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DSBs by human cell extracts is entirely dependent on TDP1 [47]. However, whether this is true in vivo is 
unclear, because SCAN1 LCLs exhibit only very mild radiosensitivity [47], and in the experiments 
reported here we failed to detect a measurable difference in the rate of DSBR following IR in SCAN1 
LCLs, using the neutral comet assay. Moreover, with respect to SSBs, cell-free assays suggest that the 
processing of 3’-phosphoglycolate is largely attributed to APE1 [48], though whether this is true in vivo is 
not known.  
           The observation that TDP1 is required for the rapid removal of SSBs created by IR has important 
clinical implications. In particular, along with our previous experiments employing H2O2 [63], the data 
presented here provide an attractive explanation for the patho-physiology of SCAN1. Reactive oxygen 
species are most likely a major source of endogenous SSBs, particularly within the brain which consumes 
approximately one quarter of inhaled oxygen and possesses relatively low levels of antioxidant enzymes 
[64]. Consequently, DNA repair mechanisms that remove oxidative DNA damage are likely to be critical 
for maintaining genetic integrity in the nervous system. It is also tempting to speculate that TDP1-
dependent SSBR may impact on normal aging. For example, the levels of 8-oxoguanine, a common 
product of oxidative stress that can trap Top1 cleavage complexes, are markedly elevated in the promoters 
of many genes that become down-regulated in an age-dependent manner, suggesting that there is increased 
oxidative stress and thus increased demand for TDP1-dependent SSBR in aged cells [65]. The results 
described here also highlight the possible advantage of inhibiting TDP1 during radiotherapy. TDP1 
inhibitors may improve cell killing by radiotherapy, particularly in tumors that possess elevated levels of 
TDP1 activity. Interestingly, increased TDP1 levels and activity have been recently reported in non-small 
cell lung cancer [66]. 
                TDP1 is highly conserved among species, with an extended amino terminus in human TDP1 that 
is either absent or poorly conserved in lower eukaryotes [67]. This amino terminus is dispensable for 
enzymatic activity, and instead appears to serve a regulatory function. For example, this domain is 
necessary for stimulation of TDP1 by Mn2+ [68], and for its association with the SSBR machinery via 
direct interaction with DNA Lig3α [28]. In vitro studies suggest that nicks are poor substrates for TDP1, 
compared to single-stranded termini or blunt-end substrates [49,69]. However, TDP1 is clearly a 
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component of the SSBR machinery and is operating at SSBs in cells [28,30,31]. These observations may 
in part be reconciled by our observation that TDP1 activity was weakly stimulated on Top1 associated 
SSBs in vitro in the presence of XRCC1/Lig3∝. This stimulation was observed primarily at low enzyme 
concentration, when levels of TDP1 were limiting. These observations are consistent with the finding that 
nuclear extracts from rodent cells lacking XRCC1/Lig3∝ show decreased TDP1 activity [30].  
               In summary, this work provides the first evidence for a requirement for TDP1 for the rapid repair 
of IR-induced DNA SSBs. Pharmacologic inhibition of TDP1 may therefore be an efficient strategy for 
sensitizing certain types of tumours to radiotherapy. 
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 Figure Legends 
 
Figure 1 Defective repair of ionizing radiation-induced DNA single-strand breaks in SCAN1 cells. 
Lymphoblastoid cells derived from SCAN1 patients (1635, 1662, and 1664) homozygous for the TDP1 
mutation H493R, or from a heterozygous (1670) or normal individuals (1646, 1688, and 702), were 
exposed to γ-ray (20Gy) in complete medium on ice (RO), and then incubated at 37°C for 30 min (R30) or 
60 min (R60) repair periods. Cells were then washed with pre-chilled PBS and subjected to alkaline comet 
assays. (A) Mean tail moments were quantified for 100 cells/sample/experiment and data are the average 
of three independent experiments (±SEM). Top, representative mock-treated (-IR) or γ-irradiated (+IR; 
20Gy) 1688 cells in the alkaline comet assay. (B) The mean fraction of DNA strand breaks remaining 
(±SEM) at the indicated time points.  Asterisks denote statistically significant (P < 0.05; t-test) differences 
between SCAN1 and normal histograms at the indicated time points. (C) Representative scatter plots from 
one of the experiments included in Panel A, showing comet tail moments of 100 individual cells per 
sample (cells numbered from 0-100) at the time points indicated.  
 
Figure 2 Repair of ionizing radiation-induced DNA double-strand breaks in SCAN1 cells. Wild-type 
(1646), SCAN1 (1635), and Lig4 syndrome (NBS2304) lymphoblastoid cells were exposed to γ-ray 
(20Gy) in complete medium on ice (RO) and then incubated at 37°C for 60 min (R60), 180 min (R180), or 
360 min (R360) repair periods. Cells were then washed with pre-chilled PBS and subjected to neutral 
comet assays. (A) Mean tail moments were quantified for 100 cells/sample/experiment and data are the 
average of three independent experiments (±SEM).  (B) The mean fraction (±SEM) of γ-ray induced 
DSBs remaining at the indicated time points.  
 
Figure 3 Reduced levels of CPT-induced Strand Breaks in SCAN1 cells pre-treated with the 
proteasome inhibitor MG-132. (A) Wild-type (1646) and SCAN1 (1635) lymphoblastoid cells were 
 14
incubated with 14 μM camptothecin for 1 hr at 37°C with (CPT+PI) or without (CPT) prior incubation 
with 50 μM of the proteosome inhibitor MG132 (PI) for 2 hr at 37°C.  Cells were then washed with pre-
chilled PBS and subjected to alkaline comet assays to measure DNA strand breaks. Mean tail moments 
were calculated from 100 cells/sample/experiment and data are the average of three independent 
experiments (±SEM).  (B) Representative scatter plots, from one of the experiments presented in panel A, 
showing 100 individual comet tail moments per sample (cells numbered from 0-100). (C) Left, The 
indicated cells were mock-treated (“-“) or incubated in 14 μM camptothecin for 1 hr at 37°C (“CPT”) in 
the absence (“-PI”) or presence (“+PI”) of MG-132 proteasome inhibitor, and then lysed and fractionated 
on CsCl gradients. Fractions containing Top1-DNA complexes (#7-10) were identified by immunobloting 
and pooled. 2-fold serial dilutions (three dilutions, shown top to bottom) of these fractions slot blotted 
onto nitrocellulose and immunoblotted with anti-Top1 polyclonal antibodies (ab-3825). Right, Top1 
cleavage complexes (fold-increase over background) were quantified for each of the serial dilutions 
depicted in the left panel, using ImageQuant software, and the mean value plotted (+/- 1S.D). Data are 
from one representative experiment of three independent experiments conducted.  
 
Figure 4 Reduced levels of IR-induced strand breaks in SCAN1 cells pre-treated with the 
proteosome inhibitor MG132. Wild-type (1646) or SCAN1 (1635) lymphoblastoid cells were mock 
incubated (-PI) or incubated with 50 μM of the proteosome inhibitor MG132 (+PI) for 2 hr at 37°C, 
exposed to γ-rays (20Gy) in complete medium on ice (RO), and then incubated at 37°C for 30 min (R30) 
or 60 min (R60) repair periods, in the presence or absence of MG132, as indicated. Cells were then 
washed with pre-chilled PBS and subjected to alkaline comet assays. (A) Mean tail moments were 
quantified for 100 cells/sample/experiment and data are the average of three independent experiments 
(±SEM). (B) The mean fraction of DNA strand breaks remaining (±SEM) at the indicated time points. P 
values indicate that the difference between mock-treated (-PI) and MG-132-treated (+PI) SCAN1 cells is 
statistically significant (T-test). 
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Figure 5 DNA Lig3α/XRCC1 enhances the activity of TDP1 at Top1-associated SSBs, in-
vitro. (A) Top, A single stranded 18-mer oligonucleotide with 3’-phosphotyrosine residue (18Y) 
was employed to generate a duplex substrate with a nick that contains a 3’-phosphotyrosine 
terminus, mimicking a Top1-associated SSB (inset). Bottom, 25 nM 18-Y substrate was 
incubated with 1-32 nM recombinant human TDP1 for 1 hr at 37°C. Reaction products were 
fractionated by denaturing polyacrylamide gel electrophoresis and examined by autoradiography. 
(B) 18-Y substrate was incubated with a limiting concentration of TDP1 (1 nM) in the presence 
of increasing concentrations (0.5, 1, and 2 nM) of each of the indicated proteins for 1 hr at 37°C. 
Reaction products were fractionated by denaturing polyacrylamide gel electrophoresis and 
examined by autoradiography. A representative experiment from three independent experiments 
is shown.  (C) Left, the 18-Y substrate was incubated in the absence (-) or presence of 1, 2, or 4 
nM of each of the indicated recombinant human proteins for 1 hr at 37°C. Note that in lanes 5-7, 
BSA was present at 2, 4, or 8 nM to substitute for the absence of both XRCC1 and Lig3α. 
Reaction products were fractionated by denaturing polyacrylamide gel electrophoresis and 
examined by autoradiography. Right, 18-P product was quantified by ImageQuant software and 
expressed as the fraction (%) of total labelled oligonucleotide duplex. Data are the mean (± SEM) 
of three independent experiments. 
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